Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1319
| Despition | Axin 2 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1509 | Human APOD Protein, HEK (AC1509) | 2 µg | inquiry |
| ACPP-1767 | Human YIF1B Protein (AC1767) | 5 µg | inquiry |
| ACPP-1769 | Human VAT1 Protein (AC1769) | 2 µg | inquiry |
| ACPP-1020 | Recombinant Human Neurotensin Protein (Fc Tag) (AC1020) | 50 µg | inquiry |
| ACPP-1069 | Calretinin Blocking Peptide (AC1069) | 250 µg | inquiry |
| ACPP-1716 | Mouse ANGPTL7 Protein (AC1716) | 1 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1416 | Human VAMP1 Protein (AC1416) | 20 µg | inquiry |
| ACPP-1214 | Ki67 Blocking Peptide (AC1214) | 250 µg | inquiry |
| ACPP-1094 | Recombinant Human FGFR4 Protein (Functional) (AC1094) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.